Ryali Sriram 4
4 · Eiger BioPharmaceuticals, Inc. · Filed May 11, 2021
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-10+87,000→ 87,000 totalExercise: $8.49Exp: 2031-05-09→ Common Stock (87,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from May 10, 2021 subject to Reporting Person's continuous service status as of each such date.